Verrica Pharmaceuticals Inc. (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

4.820

-0.040 (-0.82%)

At close: Aug 21, 2026, 4:00 PM EDT

4.860

+0.040 (0.83%)

After-hours: Aug 21, 2026, 7:30 PM EDT

Verrica Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.2	30.15	46.33	69.55	34.27	15.75
Short-Term Investments	-	-	-	-	-	54.6
Cash & Short-Term Investments	11.2	30.15	46.33	69.55	34.27	70.35
Cash Growth	-27.27%	-34.93%	-33.38%	102.92%	-51.29%	7.46%
Receivables	11.09	5.4	0.08	4.42	0.49	-
Inventory	2.71	2.24	2.46	1.02	-	-
Prepaid Expenses	2.62	2.8	2.31	2.55	4.36	3.97
Other Current Assets	5.02	1.96	-	-	-	-
Total Current Assets	32.64	42.54	51.18	77.53	39.12	74.33
Property, Plant & Equipment	2.03	1.86	2.58	3.62	5.33	5.5
Other Long-Term Assets	1.34	2.73	0.38	0.45	0.28	0.3
Total Assets	36.02	47.13	54.13	81.6	44.72	80.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.6	2.07	1.9	2.46	0.51	0.85
Accrued Expenses	4.14	4.03	3.09	8.17	2.43	3.01
Short-Term Debt	-	-	-	-	-	41.69
Current Portion of Long-Term Debt	-	-	12.94	-	-	-
Current Portion of Leases	0.96	0.75	0.67	0.7	0.3	0.25
Current Unearned Revenue	1.34	0.78	-	-	-	-
Other Current Liabilities	14.41	8.81	10.42	5.69	0.22	0.26
Total Current Liabilities	22.44	16.44	29.01	17.02	3.46	46.06
Long-Term Debt	-	-	30.98	42.87	-	-
Long-Term Leases	0.85	0.89	1.35	1.94	1.23	1.47
Other Long-Term Liabilities	8.41	5.07	2.65	-	-	-
Total Liabilities	31.71	22.39	63.99	61.83	4.69	47.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	352.05	349.65	297.17	250.21	203.48	171.6
Retained Earnings	-347.75	-324.91	-307.03	-230.45	-163.45	-138.97
Comprehensive Income & Other	-	-	-	-	-	-0.03
Total Common Equity	4.31	24.74	-9.86	19.76	40.03	32.61
Shareholders' Equity	4.31	24.74	-9.86	19.76	40.03	32.61
Total Liabilities & Equity	36.02	47.13	54.13	81.6	44.72	80.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.81	1.63	45.94	45.51	1.53	43.41
Net Cash (Debt)	9.39	28.52	0.39	24.04	32.75	26.95
Net Cash Growth	-	7211.79%	-98.38%	-26.60%	21.53%	-4.67%
Net Cash Per Share	0.57	2.68	0.08	5.30	9.59	9.96
Filing Date Shares Outstanding	17.18	17.18	9.18	4.24	4.19	2.75
Total Common Shares Outstanding	17.18	17.18	9.18	4.24	4.11	2.75
Working Capital	10.2	26.1	22.17	60.51	35.66	28.27
Book Value Per Share	0.25	1.44	-1.07	4.66	9.74	11.85
Tangible Book Value	4.31	24.74	-9.86	19.76	40.03	32.61
Tangible Book Value Per Share	0.25	1.44	-1.07	4.66	9.74	11.85
Machinery	-	1.21	1.79	2.17	2	1.37
Construction In Progress	-	-	-	-	2.54	2.73
Leasehold Improvements	-	0.05	0.05	0.05	0.05	0.05

SEC Filings: 10-K · 10-Q